High aims to study pot for drugs

Start-up Greenlight has attracted government funds to study cannabis oil, writes Trish Dromey

High aims to study pot for drugs

Start-up Greenlight has attracted government funds to study cannabis oil, writes Trish Dromey

James Linden, CEO and founder, Greenlight Medicines. Picture: Peter Houlihan/ Fennell
James Linden, CEO and founder, Greenlight Medicines. Picture: Peter Houlihan/ Fennell

Already a subscriber? Sign in

You have reached your article limit.

Subscribe to access all of the Irish Examiner.

Annual €130 €80

Best value

Monthly €12€6 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited